argenx SE (ARGX) PT Raised to $440 at Truist Securities on upcoming PDUFA, and 'positive read-through from nipocalimab'
Tweet Send to a Friend
(Updated - March 5, 2024 11:14 AM EST)
Truist Securities analyst Joon Lee raised the price target on argenx ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Joon Lee raised the price target on argenx ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
